# Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile

Page: https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile
Text version: https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile.md
Podcast: [The IMID Forum](https://stenobird.com/podcast/the-imid-forum-981476)
Published: 2026-04-14T13:31:19+00:00
Episode link: https://soundcloud.com/imidforum/discussing-psa-bimekizumab-in
Audio file: https://feeds.soundcloud.com/stream/2302411277-imidforum-discussing-psa-bimekizumab-in.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile
Duration seconds: 992

## Resource

Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘safety and clinical efficacy of bimekizumab in patients with active PsA who were bDMARD-naïve or TNFi-IR, and the second provided a comprehensive and updated overview of bimekizumab’s safety profile to support clinical decision-making.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-psa-bimekizumab-in-psa-clinical-efficacy-and-updated-safety-profile.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.